We serve Chemical Name:1-(2-Phenylethyl)piperazine-2,6-dione CAS:247128-18-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(2-Phenylethyl)piperazine-2,6-dione
CAS.NO:247128-18-3
Synonyms:1-phenethylpiperazine-2,6-dione
Molecular Formula:C12H14N2O2
Molecular Weight:218.25200
HS Code:2933599090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.41000
Exact Mass:218.10600
LogP:0.45420
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-phenethylpiperazine-2,6-dione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-phenethylpiperazine-2,6-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-phenethylpiperazine-2,6-dione Use and application,1-phenethylpiperazine-2,6-dione technical grade,usp/ep/jp grade.
Related News: He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1-(2-Phenylethyl)piperazine-2,6-dione manufacturer British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights. 1-(2-Phenylethyl)piperazine-2,6-dione supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers. 1-(2-Phenylethyl)piperazine-2,6-dione vendor He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 1-(2-Phenylethyl)piperazine-2,6-dione factory There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association.
